Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/14/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Chris Stirling

Wrong Chris Stirling?

Partner

Phone: +44 **********  
Local Address:  London , United Kingdom
KPMG LLP
345 Park Avenue
New York , New York 10154
United States

Company Description: KPMG LLP, the audit, tax and advisory firm (www.kpmg.com/us), is the U.S. member firm of KPMG International Cooperative ("KPMG International"). KPMG International's...   more
Background

Employment History

48 Total References
Web References
To get a better picture of ...
complianceteam.tumblr.com, 4 Jan 2013 [cached]
To get a better picture of how the policy could affect big pharma companies, I spoke with Chris Stirling, European head of chemicals and pharmaceuticals at KPMG. He explained it will be vital for brand-name drug companies to become more deliberate about how they approach India, especially since the government budget for more expensive branded medicines is less than 1% of that multibillion dollar pie. "Companies will have to carefully segment the Indian market, so that they really understand where demand will be for their products," he said
Chris Stirling, UK Head of ...
www.tax-news.com, 27 Oct 2014 [cached]
Chris Stirling, UK Head of Life Sciences for KPMG LLP, said: "To ensure continued investment in research and development, life sciences companies need to review their management and exploitation of intellectual property. They need to make sure that the true value generated from each location and activity is fully recognized and remunerated. The proposals could have the potential to significantly impact the bottom line of a large number of life sciences companies."
Stirling said that life science companies should consider four actions to assess the likely impact on their operations of the BEPS project:
...
Properly planned for, companies could simplify the choice of location for production, distribution, R&D and sales and marketing," Stirling said.
KEEPING PACE WITH A CHANGING HEALTHCARE ...
biotechandmoney.com, 1 Jan 2015 [cached]
KEEPING PACE WITH A CHANGING HEALTHCARE LANDSCAPE - Chris Stirling, Global Head of Life Sciences, KPMG
21ST CENTURY FUNDING FOR 21ST CENTURY MEDICINES - Crowdcube, Cell Therapy Ltd. and KPMG
"The business model that has powered ...
www.pir-resourcing.com, 1 April 2014 [cached]
"The business model that has powered the pharma industry over the last few decades is showing signs of fatigue - costs are skyrocketing, breakthrough innovation is ebbing, competition is intense and sales growth is flattening," comments Chris Stirling, global head of KPMG's life sciences practice.
...
Not only will this lead to new revenue streams, satisfying the demands of corporate shareholders, it will help create better understanding of medical conditions, allowing the development of more innovative, patient-centred treatments, said Mr Stirling.
"Ultimately, we need to change our perception of the pharmaceutical 'value chain' to a new 'value ecosystem' which puts the patient and the customer at its centre, with other business services wrapped around their needs. Some companies have already started to grasp the nettle and are moving in the right direction - for instance, one life sciences company we spoke to is currently working on an innovative approach to diabetes," he noted.
...
"Although healthcare demands are higher than ever before, we're also in a golden age of discovery," says Mr Stirling. "If the pharmaceutical industry is to capitalise upon this potential, it must innovate to develop new business models and find better ways to collaborate across the healthcare ecosystem - all the while putting the patient at the heart of everything it does," he concludes.
Biological marvels could keep Big Pharma healthy - DistilNFO Pharma Advisory | DistilNFO Pharma Advisory
www.distilnfo.com, 27 April 2014 [cached]
Chris Stirling, head of life sciences at KPMG, says the asset swap could be a game-changer for the industry: "We are seeing companies learn the lessons of the past.
Other People with the name "Stirling":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304